SlideShare a Scribd company logo
1 of 51
Meeting Professional  Standards of Practice DebbieOhl.com Unnecessary  Medication Use Debbie Ohl RN, NHA, M.Msc. Ohl & Associates Consultant and Educator MDSCAREPLANBUILDER.com THINKTHETHOUGHTS.com
What are  Unnecessary Medications? ,[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Question ,[object Object],DebbieOhl.com
UNNECESSARY MEDS ARE D 2 UM DebbieOhl.com
Regulatory Interrelationships ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Key Terms Linked to Unnecessary Med Use ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Failure to protect from undue adverse medication consequences and/or failure to provide medications as prescribed. ,[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
DebbieOhl.com Degree of the Problem Isolated Pattern Wide-spread Immediate Jeopardy J K L Actual  Harm G H I Potential for Harm D E F No harm  likely A B C
Adverse Drug Events ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Preventable  Adverse Drug Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
ADE Drugs in Elderly ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com JAMA 2006; 296:1858-1866; AGS 2004;52:1349-1354; NEJM 2003;348:1556-64
Surveyor Assessment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Regulator’s Looking For: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Predictability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Types of Adverse Drug Reactions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Minimizing Occurrence ,[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Factors that Produce/ Contribute to Inappropriate Drug Use ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Assessing a Possible ADR ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Safeguards   Prevention of Adverse Drug Reactions   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Polypharmacy ,[object Object],[object Object],[object Object],[object Object],DebbieOhl.com References: Stewarb RB. Polypharmacy in elderly: a fair accompli? DICP 1990; 24; 321-323.  Montamat SC, Cusack B. Overcome the problems with polypharmacy and drug misuse.  Clin Geriatr Med 1992; 8: 143-158.  LeSage J. Polypharmacy in the geriatric patient. Nurs Clin North Am 1991; 26: 273-287 .
  Possible Impacts of Polypharmacy ,[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Preventing Polypharmacy Gather information ,[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
DebbieOhl.com Resident Medication Profile Medications (brand and generic) Drug Class Clinical indication Common Side  Effects Expected Response
Preventing Polypharmacy  Eliminate, Substitute and Simplify ,[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Medication Errors ,[object Object],DebbieOhl.com
Pharmaceutical Process Where Drug Errors are Most Likely to Occur ,[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
DebbieOhl.com Process Causative Problems & Reasons For Potential Solutions Prescribing Transcribing Dispensing  Administering
Citations for violations of  drug-misuse rules have increased by nearly 40% since 2004, according to CMS.   DebbieOhl.com
beers DebbieOhl.com
Psychoactive Medications THINK ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Causes of  Behavior Disturbances   ,[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Behavioral Disturbance Prompting PA Med Use ,[object Object],[object Object],[object Object],DebbieOhl.com
Cognitive Compromise ,[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
ALTERED MENTAL STATUS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
DebbieOhl.com 1. Emotionally Labile   2. Pathological Emotions   3. Catastrophic Reactions  Mood Disturbances
Treatment Principles  Psychoactive Medications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Behavior Questions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Questions for Behavior & PA Meds ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Questions for Depression & PA Meds ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Antipsychotic Meds Can you justify use? ,[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
  Anti-Anxiety Med Questions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Beers Criteria  Anticholinergic Medications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
  Beers Criteria  Antihypertensives ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
  Beers Criteria  Antianxiety/ Sedative Agents  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Beers Criteria  Antipsychotics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Beers Criteria  Antidepressants ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Minimize Unnecessary Drug Use   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Assessment Tools for Benchmarking Behavior ,[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
Assessment Tools for Benchmarking Behavior Cont’ ,[object Object],[object Object],[object Object],[object Object],DebbieOhl.com
DebbieOhl.com ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],The FUNDAMENTAL ISSUES to be addressed in CMS guidelines the lack of clear,  solid clinical rational for use of the specific medication identified .

More Related Content

What's hot

07 what is casuality assesment
07 what is casuality assesment07 what is casuality assesment
07 what is casuality assesment
Prabir Chatterjee
 
Polypharm presentation
Polypharm presentationPolypharm presentation
Polypharm presentation
Lisa Tripp
 
2016: Considerations on Polypharmacy and Adverse Drug Events-Watanabe
2016: Considerations on Polypharmacy and Adverse Drug Events-Watanabe2016: Considerations on Polypharmacy and Adverse Drug Events-Watanabe
2016: Considerations on Polypharmacy and Adverse Drug Events-Watanabe
SDGWEP
 

What's hot (20)

07 what is casuality assesment
07 what is casuality assesment07 what is casuality assesment
07 what is casuality assesment
 
Polypharmacy in Psychiatry
Polypharmacy in PsychiatryPolypharmacy in Psychiatry
Polypharmacy in Psychiatry
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
ADVERSE DRUG REACTION
ADVERSE DRUG  REACTIONADVERSE DRUG  REACTION
ADVERSE DRUG REACTION
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
The Highs And Lows Of Opiate Management
The Highs And Lows Of Opiate ManagementThe Highs And Lows Of Opiate Management
The Highs And Lows Of Opiate Management
 
Adverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and ClassificationAdverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and Classification
 
Beer's list 2015 update
Beer's list 2015 updateBeer's list 2015 update
Beer's list 2015 update
 
Severity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessmentSeverity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessment
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
Polypharm presentation
Polypharm presentationPolypharm presentation
Polypharm presentation
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
2016: Considerations on Polypharmacy and Adverse Drug Events-Watanabe
2016: Considerations on Polypharmacy and Adverse Drug Events-Watanabe2016: Considerations on Polypharmacy and Adverse Drug Events-Watanabe
2016: Considerations on Polypharmacy and Adverse Drug Events-Watanabe
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Geriatrics and drugs
Geriatrics and drugs Geriatrics and drugs
Geriatrics and drugs
 
Polypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic managementPolypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic management
 
Adverse drug reaction sjk
Adverse drug reaction sjkAdverse drug reaction sjk
Adverse drug reaction sjk
 
Adverse event reporting
Adverse event reportingAdverse event reporting
Adverse event reporting
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 

Similar to Unnecesary Medication Use in Long Term Care Facilites

Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)
Shaukat Patel MS R.Ph.
 
Orientation To Pharmacology
Orientation To PharmacologyOrientation To Pharmacology
Orientation To Pharmacology
Tpetrici
 
Administer and monitor s8 meds
Administer and monitor s8 medsAdminister and monitor s8 meds
Administer and monitor s8 meds
elsavdh2
 
Drug a boon or a curse
Drug   a boon or a curseDrug   a boon or a curse
Drug a boon or a curse
Pooja Sharma
 
Guyton adhd whirlwind new
Guyton adhd whirlwind newGuyton adhd whirlwind new
Guyton adhd whirlwind new
UCAYAofSC
 
Gen rx power point
Gen rx power pointGen rx power point
Gen rx power point
progroup
 

Similar to Unnecesary Medication Use in Long Term Care Facilites (20)

Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
 
Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)Med safety nj ph a 10 10 11 final 3 (97-2003)
Med safety nj ph a 10 10 11 final 3 (97-2003)
 
The Triple Challenge: Optimizing HIV Treatment for Patients with Co-occurring...
The Triple Challenge:Optimizing HIV Treatment for Patients with Co-occurring...The Triple Challenge:Optimizing HIV Treatment for Patients with Co-occurring...
The Triple Challenge: Optimizing HIV Treatment for Patients with Co-occurring...
 
Orientation To Pharmacology
Orientation To PharmacologyOrientation To Pharmacology
Orientation To Pharmacology
 
Administer and monitor s8 meds
Administer and monitor s8 medsAdminister and monitor s8 meds
Administer and monitor s8 meds
 
Drug a boon or a curse
Drug   a boon or a curseDrug   a boon or a curse
Drug a boon or a curse
 
Drug a boon or a curse
Drug   a boon or a curseDrug   a boon or a curse
Drug a boon or a curse
 
Medication error- In Multidisciplinary Hospital
Medication error- In Multidisciplinary HospitalMedication error- In Multidisciplinary Hospital
Medication error- In Multidisciplinary Hospital
 
The Psychology and Neurology of Substance Related Disorders
The Psychology and Neurology of Substance Related DisordersThe Psychology and Neurology of Substance Related Disorders
The Psychology and Neurology of Substance Related Disorders
 
Principles of psychopharm[1]
Principles of psychopharm[1]Principles of psychopharm[1]
Principles of psychopharm[1]
 
1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx
 
drugs abuse , tolerances, addiction
drugs abuse , tolerances, addiction drugs abuse , tolerances, addiction
drugs abuse , tolerances, addiction
 
Guyton adhd whirlwind new
Guyton adhd whirlwind newGuyton adhd whirlwind new
Guyton adhd whirlwind new
 
Michael Guyton, M.D. ADHD Whirlwind
Michael Guyton, M.D. ADHD Whirlwind Michael Guyton, M.D. ADHD Whirlwind
Michael Guyton, M.D. ADHD Whirlwind
 
Medical history interview
Medical history interview Medical history interview
Medical history interview
 
Managing medication
Managing medicationManaging medication
Managing medication
 
Managing medicine safety
Managing medicine safetyManaging medicine safety
Managing medicine safety
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
 
Gen rx power point
Gen rx power pointGen rx power point
Gen rx power point
 

More from Debbie Ohl

Indian spirituality
Indian spiritualityIndian spirituality
Indian spirituality
Debbie Ohl
 
Sm From Paper To Person 9 22 10
Sm From Paper To Person 9 22 10Sm From Paper To Person 9 22 10
Sm From Paper To Person 9 22 10
Debbie Ohl
 

More from Debbie Ohl (10)

Connecting to self
Connecting to selfConnecting to self
Connecting to self
 
Connecting to Self.
Connecting to Self.Connecting to Self.
Connecting to Self.
 
Personal Strategic Planning
Personal Strategic PlanningPersonal Strategic Planning
Personal Strategic Planning
 
Indian spirituality
Indian spiritualityIndian spirituality
Indian spirituality
 
Sm From Paper To Person 9 22 10
Sm From Paper To Person 9 22 10Sm From Paper To Person 9 22 10
Sm From Paper To Person 9 22 10
 
Sm from paper to person 9 22 10 speaker copy
Sm from paper to person 9 22 10   speaker copySm from paper to person 9 22 10   speaker copy
Sm from paper to person 9 22 10 speaker copy
 
Emotional Clarity In Your Life
Emotional Clarity In Your LifeEmotional Clarity In Your Life
Emotional Clarity In Your Life
 
Putting Parents to Work for your Retention Office
Putting Parents to Work for your Retention OfficePutting Parents to Work for your Retention Office
Putting Parents to Work for your Retention Office
 
How to Convert the Concept of Excellence into a Daily Reality
How to Convert the Concept of Excellence into a Daily RealityHow to Convert the Concept of Excellence into a Daily Reality
How to Convert the Concept of Excellence into a Daily Reality
 
Care Planning
Care PlanningCare Planning
Care Planning
 

Unnecesary Medication Use in Long Term Care Facilites

  • 1. Meeting Professional Standards of Practice DebbieOhl.com Unnecessary Medication Use Debbie Ohl RN, NHA, M.Msc. Ohl & Associates Consultant and Educator MDSCAREPLANBUILDER.com THINKTHETHOUGHTS.com
  • 2.
  • 3.
  • 4. UNNECESSARY MEDS ARE D 2 UM DebbieOhl.com
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. DebbieOhl.com Degree of the Problem Isolated Pattern Wide-spread Immediate Jeopardy J K L Actual Harm G H I Potential for Harm D E F No harm likely A B C
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24. DebbieOhl.com Resident Medication Profile Medications (brand and generic) Drug Class Clinical indication Common Side Effects Expected Response
  • 25.
  • 26.
  • 27.
  • 28. DebbieOhl.com Process Causative Problems & Reasons For Potential Solutions Prescribing Transcribing Dispensing Administering
  • 29. Citations for violations of drug-misuse rules have increased by nearly 40% since 2004, according to CMS. DebbieOhl.com
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36. DebbieOhl.com 1. Emotionally Labile 2. Pathological Emotions 3. Catastrophic Reactions Mood Disturbances
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.

Editor's Notes

  1. Meds are a key component in the clinical process. The guidelines are intended to insure medication use is of value and necessary. T Significant emphasis is placed on preventing and recognizing adverse drug reactions ASAP. Consequently, surveyors will expect to see: Rationale for use Parameters for monitoring Prompt recognition and evaluation of new onset problems and conditions worsening Consideration for dose reduction and discontinuance as appropriate.
  2. Excessive doses : given at one time or over a period of time Excessive duration : longer than required or needed Without adequate monitoring : not paying attention to changes or outcomes occurring Without adequate indications for use : failure to establish rationale for use Presence of adverse consequences indicating dose should be reduced or discontinued : Failure to recognize change and / or take action as indicated or needed.
  3. In your facility what might you consider as unnecessary and why? UNNECESSARY MEDS ARE D 2 UM
  4. DOSE, DURATION, USE, and MONITORING are not in place
  5. There are 5 questions to consider to prevent connecting these tags to one another Do the target symptoms warrant medications? Are non-pharmacological interventions in place and relevant? Is medication appropriate to manage the symptoms or condition? Do the intended or actual benefits justify the risk of use? Is there a system in place and to insure these processes are adhered to?
  6. 1. ADVERSE DRUG EFFECT: collective b asket term that captures med errors and ADR’s. Statistically: 2 ADE’s /100 residents More than half of adverse drug events may be preventable. ADEs can have different outcomes: worsening of existing condition, or lack of expected improvement. 2. ADVERSE DRUG REACTION: Any unintended response to a drug that is Harmful / noxious in doses for diagnosis, prophylaxis, or therapy. High risk med categories: Psycho tropics, analgesics, anticoagulants, antibiotics, cardiovascular 3. Polypharmacy : lots of meds 4. Predicatblitiy: primary concern 5. MEDICATION ERRORS Any preventable event that can cause or lead to inappropriate medication use or patient harm while the medication is in control of the health professional. DAMP Mistakes are related to prescribing , dispensing, administering, or monitoring drug. 5 errors / 100 residents 6. BEERS LIST: medication with high risk side effects that outweigh benefits of use, meds that are inappropriate at any dose, specific meds used at low dose meds used with caution. 7. Immediate Jeopardy: H I L K L 8. STANDARDS of PRACTICE: include the various practice regulations in each State, and commonly accepted health standards established by national organizations, boards and councils.
  7. Group exercise: From a citation perspective, what are the potential scope and severity of these and why?
  8. Pharmacodynamics : The response of the body to the drug ; It is the time course and effect of the drugs on cellular and organ function. With aging there is increased sensitivity R/I > ADR’s and toxcity. Problems tend to occur when two or more drugs together can “add up” to increase effect, magnify or inhibit the effect of the other med. Pharmacokinetics : what the body does to a drug ABSORPTION: bowel surface decreases with age and gastric juices increase. DISTRIBUTION: Total body water decreases 10 to 15% with aging. Results in possible higher blood concentrations of some water-soluble drugs Body weight that is body fat increases from 18 to 36% in men and from 33 to 45% in women. Result is fat soluble drugs take longer to eliminate. METABOLISM: liver mass and blood flow decrease = harder to breakdown and eliminate ELIMINATION: renal mass and blood flow decrease = reduced elimination of drug. BOTTOM LINE : Long Term and Maintenance therapy requires dose adjusted reviews especially with acute illness and dehydration.
  9. 35% of older persons experience ADEs and almost half of these are preventable. 5 med errors for every100 residents 14% of hip fractures are related to PA med 100 ADE’s for every 100 residents An adverse drug reaction is any unexpected, unintended, undesired, or excessive response to a drug that: Requires discontinuing the drug (therapeutic or diagnostic) Requires changing the drug therapy Requires modifying the dose (except for minor dosage adjustments) Necessitates admission to a hospital Prolongs stay in a health care facility Necessitates supportive treatment Significantly complicates diagnosis Negatively affects prognosis Results in temporary or permanent harm, disability, or death System issues at the facility are a key concern of regulators which gives as pause to determine how Preventable Adverse Drug Effects come about. Occur at Ordering Wrong drug choice PA v. pain med Failure to consider drug interactions pharm v diet Transcription errors Nsg, md, pharm Occurr at Monitoring Failure to order specific monitoring needs: blood test md, pharm, nsg Delayed response or failure to respond to signs & symptoms of toxicity or lab evidence of toxicity: NF system issues, oversight, FU day to day, and qa DRUG CLASSES OF CONCERN; Diuretics, ANTI’s, Hypnotics
  10. Start low and go slow. Monitor for potential side effects i.e. mental status changes
  11. 1. Indications / reasons for use: Assessment and rationale 2. Effectiveness, dose: Baseline, dose range, expected outcome and time line to see it 3. Monitoring: drug regimen, response to irregularities: MUST ESTABILISH BASELINE, 4 gatekeepers: direct care, charge nurse, physician, pharmacist 4. Duplication of drug therapy: same class, similar side effects 5. Presence of Adverse Drug Events: predictable verses unpredictable 6. Weight history of note: gain or loss, anorexia, dysphagia /swallowing problems 7. Hydration / intake records of note: evaluation of change in hydration, fluid, electrolyte balance
  12. Comprehensive Assessment Based on assessment of condition, risk, needs, behaviors Quality of Care: Lethargy, sedation, bowel problems, sleep disturbance, increased pain ADL decline: NEW or rapid decline; decline in function or tolerance Urinary Incontinence: change in function or status Mental and Psychosocial function: change in behavior> depression, mood, agitation, restlessness, increased confusion, delirium Physician Services: Medical Director: Procedures in place to resolve concerns Pharmacy Services:Medical Regimen Review
  13. Use as a key to keep surveyors on track and as response criteria on 2567’s . Reactions can be immediate as in anaphylaxis, but generally requires 5 days of treatment, most show by 12 weeks
  14. Prevalence of ADR-related hospitalizations ranges from 5% to 35%. ADEs are estimated to cost the health care system $75 billion to $85 billion annually Drug / Drug Interactions: PHARMACOKINETICS AND DYNAMICS 40% elderly at risk Drug / Nutrient Interactions: Allergic Reactions / Hypersensitivity Drug Toxicity: concurrent use of different drugs with same toxcity side effects Idiosyncratic Reaction Complications DRUG / DISEASE INTERACTIONS: exacerbation of the disease by the drug (i.e. anti-cholinergic are the MOSY common cause: glaucoma, BPH, ALTZ, dry eye
  15. The pharmacist is the primary gatekeeper: Monthly or more often (worsening status first 30 days). MRR (medication record review) is designed to: Prevent Identify Report Resolve MRP’s
  16. 1. Underuse of medications Untreated indications . The patient has a medical problem that requires drug therapy but is not receiving a drug for that indication. Subtherapeutic dosage . The patient has a medical problem that is being treated with too little of the correct medication. 2 . Overuse of medications Drug use without indication . The patient is taking a medication for no medically valid indication. Overdosage . The patient has a medical problem that is being treated with too much of the correct medication. 3. Use of inappropriate medications Improper drug selection . The patient has a drug indication but is taking the wrong drug, or is taking a drug that is not the most appropriate for the special needs of the patient. 4. Adverse drug reactions, including drug interactions Adverse drug reactions . The patient has a medical problem that is the result of an adverse drug reaction or adverse effect. Drug interactions. The patient has a medical problem that is the result of a drug-drug, drug-food, or drug-laboratory test interaction. 5. Lack of assessment 6. Lack of monitoring 7. Lack of recognition of ADR’s 8. Lack of adherence to drug therapy (patient noncompliance) Failure to receive medication. The patient has a medical problem that is the result of not receiving a medication due to economic, psychological, sociological, or pharmaceutical reasons.
  17. Review the current medications : CALL PHARMACIST and ask!. 2. Assess other possible causes for signs and symptoms: PMS/E 3. Validate the drug ordered is the drug given: ck drug, dose, freq against MAR and order 4. Verify that the onset of the event was AFTER drug administration initiated. 5d-12wk 5.Determine the time interval between the beginning of drug treatment and the onset of the event. Does it fit with pharmocdynamics?
  18. AVOID the prescribing cascade (example in context).
  19. What medications does the resident really need and why?
  20. Know and report the meds/dosages resident is taking when requesting orders.
  21. Go to next slide for group exercise
  22. CMS suspect the drugs, which come with warnings of serious side effects and require careful monitoring, are being overused for people with behavior problems, especially in facilities without the staff or training to first try to calm residents by other means. CAUSES AND CURES: Policies, procedures, protocols Education IDT Team involvement Monitoring: assessment, POC interventions, implementation, effectiveness Created most used meds cheat sheet facts Quick recognition monitoring system
  23. The Beers criteria list identifies medications with High risk side effects outweighing any benefit the medication may have at any dose, for any indication Medications to be used with caution at certain doses and for specific indications
  24. Altered cognition : Delirium, dementia, catastrophic reactions/task failure, schizophrenia, and mental illness/retardation. Altered emotions: There are different types of depression. Reactive, the most common; Affective, a recurrent mood disorder; Symptomatic/Secondary, related to neurological disease. Disturbances of mood: Emotional labiality precipitated by thoughts, and/or circumstances; or pathological, related to disease processes such as multiple sclerosis or strokes. Physical Illness altering level of consciousness, infection, pain or disfigurement can create behavioral disturbances. The key question: Is the behavior change consistent with physical illness? Drug toxicity: Is the behavior drug induced? Can you make a correlation with drug use and onset of behavior? Don’t be fooled by a lab test that indicates drug is within therapeutic range. Drug toxicity can be present in the elderly despite “normal” lab reports.
  25. Aggression offensive = ASSUALTIVE defensive = RESISTIVE Stimulus internal = delusion / hallucination external = environment, light, noise, certain people
  26. Amnesia: inability to learn new information. Aphasia: Difficult comprehension; unable to follow instructions; unable to participate in conversation; unable to express need. Apraxia: Loss of ability to do learned motor skills Agnosia: Loss of ability to recognize objects
  27. Is there supporting criteria for the drug category being used? If so, Is behavior a threat, distressing or harmful to self or others?
  28. Are they high risk Cognitively impaired, psychotic, manic depressive Are they low risk? What are the symptoms? Verbal abuse, physical; abuse, socially inappropriate What is the frequency? What is the severity? What is the ease of alterability?
  29. If easily altered and receiving antidepressant are they a candidate for reduction? If not, why not? If so, what is the plan and what are the potential risk? If NOT easily altered and receiving antidepressant how long has med been given? Is there a need to adjustment or change? If not, why? If NOT easily altered and NOT receiving antidepressant are they a candidate? If not why not and what are the risk and concerns? What is the plan for managing?
  30. Continued Use? Drug Reduction attempted? If contraindicated record clearly demonstrates why. Are symptoms easily altered? If so, consider length of use & possible reduction program. If not , how long on med? Has there been any improvement? If not new drug is higher dose indicated OR reassess cause factors? Are other psychoactives in use? Has ADR presence / potential investigated?
  31. If Use is PRN Is it given pro-actively to facilitate treatment or calm in anticipation of predicable reaction? Is there a care plan in place for this? Is effectiveness noted? Is med used in response to behavior outburst or mood problem? Could that outburst have been anticipated and dealt with non-medically and/or proactively with medication? Is care plan in place? Is there documentation of need and interventions tried prior to administration? Is effectiveness noted? Is there monitoring for adverse effects?
  32. Staff training on implication of cognitive loss & CATASTROPHIC RESPONSES. Sensitizing staff to resident perspective. Quality assurance oversight. Drug usage Relationship of functional status to drug use Accuracy of assessment Effectiveness of care plan Staff comprehension of cognitive loss, mood and behavior problems. Develop drug protocols. Effective communication with physician. Accurate assessment and ongoing evaluation. Consistent implementation of the care plan.